Neuroguard IEP® System NG-NV-7-40Recalls & reported problems
Contego Medical, Inc. · The Neuroguard IEP System consists of three main components: • A self-expanding nitinol stent • A delivery catheter which includes a post-dilation balloon and activation handle • Embolic protection filter that is integrated at the distal end of the delivery system · Class 3
All models of Neuroguard IEP System (8)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
2 open recalls name this device. See the recall details and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 8
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 2
Summary
The FDA's MAUDE database contains 8 adverse event reports that list this exact device (DI 00851616007620), received between Jun 11, 2026 and Aug 30, 2026 — classified as 8 malfunctions.
The most frequently reported specific device problem is “Activation Problem” (5 reports).
2 FDA recall records name this device's identifier, 2 still open.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Recalls naming this device
- Jun 29, 2026Class IIOpen, Classified
Carotid stent and post-dilation balloon system with integrated embolic protection system has an integrated filter, that due to a wire-to-filter-bond issue, may fail to open following sheath retraction; and if this condition were to occur during a procedure, the result may be loss of intended integrated embolic protection.
Z-2911-2026 · Root cause: Process control · Recall details · FDA record ↗
- Sep 4, 2025Class IIOpen, Classified
Carotid stent and post-dilation balloon system with integrated embolic protection system has an integrated filter that may not open or may not fully open during sheath retraction and operation of the filter knob. The stent is used with a primary distal embolic protection device.
Z-0131-2026 · Root cause: Device Design · Recall details · FDA record ↗
Most reported problems
Device problems
- Activation Problem5
- Appropriate Device Problem Term/Code Not Available2
- Activation Failure1
- Misassembled During Installation1
Patient problems
- No Clinical Signs, Symptoms or Conditions8
Recent adverse event reports
The 8 most recent of 8 reports, in the reporter's own words as published by the FDA.
MalfunctionAug 30, 2026Activation Failure; Activation Problem
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 50512696 ↗MalfunctionJul 10, 2026Activation Problem
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 25783352 ↗MalfunctionJul 10, 2026Activation Problem
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 25783136 ↗MalfunctionJul 10, 2026Activation Problem
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 25782949 ↗MalfunctionJul 10, 2026Activation Problem
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 25782787 ↗MalfunctionJun 11, 2026Appropriate Device Problem Term/Code Not Available
IT WAS REPORTED THAT DEPOLOYMENT ISSUES OCCURRED WITH THE NEUROGUARD STENT IEP NG-NV-7-40, SPECIFICALLY THAT THE DEVICE WAS UNABLE TO DEPLOY. NO PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT. MULTIPLE ATTEMPTS WERE MADE IN A GOOD FAITH EFFORT TO COLLECT ADDITIONAL INFORMATION REGARDING THE EVENT. THE EVENT DATE WAS CONFIRMED AS DECEMBER 9, 2025. A STEP BY STEP ACCOUNT OF EXACTLY WHAT OCCURRED WITH DEPLOYMENT ISSUES WAS ASKED AND WAS UNKNOWN. THIS IS THE TOTALITY OF THE INFORMATION AVAILABLE AT THIS TIME.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 25477395 ↗MalfunctionJun 11, 2026Misassembled During Installation
IT WAS REPORTED THAT DURING A PROCEDURE TO TREAT PLAQUE IN THE DISTAL LEFT INTERNAL CAROTID ARTERY USING THE NEUROGUARD STENT IEP SYS NG-NV-7-40, THE STENT COULD NOT BE DEPLOYED AS INTENDED. THE TARGET LESION WAS CHARACTERIZED BY MODERATE CALCIFICATION, 50% STENOSIS, A LENGTH OF 40 MM, AND AN ARTERY DIAMETER OF 8.0 MM. EMBOLIC PROTECTION WAS USED. THE IFU (INSTRUCTION FOR USE) WAS FOLLOWED DURING PREPARATION, PROCEDURE, POST-PROCEDURE WITHOUT ISSUE. THE THUMB WHEEL COULD NOT BE USED TO CONTINUE STENT DEPLOYMENT, AND ALTHOUGH THE FILTER COULD BE OPENED AND CLOSED, THE STENT ITSELF COULD NOT BE DEPLOYED. WE WERE ABLE TO PULL THE PIN FROM HANDLE AND SLOWLY ROLL THUMB WHEEL CLOSED, THE STENT ITSELF COULD NOT BE DEPLOYED. WE WERE ABLE TO PULL THE PIN FROM HANDLE AND SLOWLY ROLL THUMB WHEEL DOWN AND WERE ABLE TO GET FILTER OPENED, BUT UNABLE TO GET WHEEL TO CONTINUE TO DEPLOY STENT. WE CLOSED FILTER AND OPENED BACK UP AND STILL THE SAME. CLOSED FILTER AND BROUGHT DEVICE OUT. THE DEVICE WAS SAFETY REMOVED AND REPLACED WITH A NEW NEUROGUARD NG-NV-7-40 FROM THE SAME LOT WHICH DEPLOYED WITH NO PROBLEM TO COMPLETE THE PROCEDURE. NO PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 25477119 ↗MalfunctionJun 11, 2026Appropriate Device Problem Term/Code Not Available
LIMITED INFORMATION WAS REPORTED THAT WHEN THE PHYSICIAN WENT TO DEPLOY THE NEUROGUARD STENT ISP SYS NV-NV-7-40, THE STENT WOULD NOT DEPLOY. PHYSICIAN KEPT USING THE THUMB WHEEL TO DEPLOY BUT THE STENT WAS NOT COMING OUT. NO PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT. ADDITIONAL INFORMATION WAS RECEIVED: DR. XXX WAS TREATING AN INTERNAL CAROTID ARTERY STENOSIS WITH THE NEUROGUARD. THE NEUROGUARD WAS ADVANCED TO THE TARGET LESION. THE 40 MICRON FILTER WAS DEPLOYED. WHEN ATTEMPTING TO NEXT DEPLOY THE NEUROGUARD STENT, THE THUMBWHEEL DID NOT MOVE, THE NEUROGUARD FILTER WAS CLOSED AND THE NEUROGUARD DELIVERY SYSTEM WAS REMOVED FROM THE CIRCULATION WITHOUT DIFFICULTY. A NEW NEUROGUARD WAS THEN USED TO TREAT THE PATIENT AND PERFORMED WITHOUT ANY ISSUES. THERE WERE NO PATIENT COMPLICATIONS.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 25476891 ↗
Other Stent, Carotid devices
- Neuroguard IEP® System NG-0740-140-2Contego Medical, Inc. · Stent, Carotid2 recalls32 reports
- Neuroguard IEP® System NG-NV-6-40Contego Medical, Inc. · Stent, Carotid2 recalls9 reports
- ENROUTE Transcarotid Stent SR-0940-CSSilk Road Medical, Inc. · Stent, Carotid1 recall5 deaths58 reports
- Neuroguard IEP® System NG-0640-140-2Contego Medical, Inc. · Stent, Carotid2 recalls7 reports
- ENROUTE Transcarotid Stent SR-1040-CSSilk Road Medical, Inc. · Stent, Carotid1 recall3 deaths56 reports
- CGuard Prime Carotid Stent System CND0840Inspire M.D Ltd · Stent, Carotid1 recall1 death41 reports
- CGuard Prime Carotid Stent System CND0940Inspire M.D Ltd · Stent, Carotid1 recall31 reports
- ENROUTE Transcarotid Stent SR-0930-CSSilk Road Medical, Inc. · Stent, Carotid1 recall1 death21 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026 · each recall links to the FDA recall notice
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page